ZFHX3 has been established as a tumor suppressor in prostate cancer in our previous studies, as its gene undergoes frequent somatic mutations in advanced prostate cancer33,34 and its deletion in mouse prostates causes neoplastic lesions and promotes Pten deletion-induced tumorigenesis35,36. This evidence concerns the gene ZFHX3 and prostate carcinoma.